106 related articles for article (PubMed ID: 7685390)
1. Synthesis of human CCK26-33 and CCK-33 related analogues on 2,4-DMBHA and TMBHA.
Miranda MT; Liddle RA; Rivier JE
J Med Chem; 1993 Jun; 36(12):1681-8. PubMed ID: 7685390
[TBL] [Abstract][Full Text] [Related]
2. Total synthesis, purification, and characterization of human [Phe(p-CH2SO 3Na)52, Nle32,53,56, Nal55]-CCK20-58, [Tyr52, Nle32,53,56, Nal55]-CCK-58, and [Phe(p-CH2SO3Na)52, Nle32,53,56, Nal55]-CCK-58.
Miranda MT; Craig AG; Miller C; Liddle RA; Rivier JE
J Protein Chem; 1993 Oct; 12(5):533-44. PubMed ID: 7511387
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
[TBL] [Abstract][Full Text] [Related]
4. Solid phase synthesis of a fully active analogue of cholecystokinin using the acid-stable Boc-Phe (p-CH2) SO3H as a substitute for Boc-Tyr(SO3H) in CCK8.
Gonzalez-Muniz R; Cornille F; Bergeron F; Ficheux D; Pothier J; Durieux C; Roques BP
Int J Pept Protein Res; 1991 Apr; 37(4):331-40. PubMed ID: 1894448
[TBL] [Abstract][Full Text] [Related]
5. Full agonists of CCK8 containing a nonhydrolyzable sulfated tyrosine residue.
Marseigne I; Roy P; Dor A; Durieux C; Pélaprat D; Reibaud M; Blanchard JC; Roques BP
J Med Chem; 1989 Feb; 32(2):445-9. PubMed ID: 2464062
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin peptides stimulate pancreatic secretion by multiple signal transduction pathways.
Yoshida H; Tsunoda Y; Owyang C
Am J Physiol; 1997 Sep; 273(3 Pt 1):G735-47. PubMed ID: 9316479
[TBL] [Abstract][Full Text] [Related]
8. 2-Phenylethyl ester and 2-phenylethyl amide derivative analogues of the C-terminal hepta- and octapeptide of cholecystokinin.
Fulcrand P; Rodriguez M; Galas MC; Lignon MF; Laur J; Aumelas A; Martinez J
Int J Pept Protein Res; 1988 Nov; 32(5):384-95. PubMed ID: 2463231
[TBL] [Abstract][Full Text] [Related]
9. Correlation between phospholipid breakdown, intracellular calcium mobilization and enzyme secretion in rat pancreatic acini treated with Boc-[Nle28, Nle31]-CCK-7 and JMV180, two cholecystokinin analogues.
Lignon MF; Galas MC; Rodriguez M; Martinez J
Cell Signal; 1990; 2(4):339-46. PubMed ID: 1701321
[TBL] [Abstract][Full Text] [Related]
10. Investigation of peripheral cholecystokinin receptor heterogeneity by cyclic and related linear analogues of CCK26-33: synthesis and biological properties.
Charpentier B; Durieux C; Menant I; Roques BP
J Med Chem; 1987 Jun; 30(6):962-8. PubMed ID: 2438407
[TBL] [Abstract][Full Text] [Related]
11. The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini.
Sarri E; Ramos B; Salido GM; Claro E
Br J Pharmacol; 2001 Aug; 133(8):1227-34. PubMed ID: 11498507
[TBL] [Abstract][Full Text] [Related]
12. Replacement of Tyr-SO3H by a p-carboxymethyl-phenylalanine in a CCK8-derivative preserves its high affinity for CCK-B receptor.
McCort-Tranchepain I; Ficheux D; Durieux C; Roques BP
Int J Pept Protein Res; 1992 Jan; 39(1):48-57. PubMed ID: 1378822
[TBL] [Abstract][Full Text] [Related]
13. Relative bioactivities of cholecystokinins-8 and -33 on rat pancreatic acini.
Liddle RA; Elashoff J; Reeve JR
Peptides; 1986; 7(5):723-7. PubMed ID: 2432584
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.
Rodriguez M; Galas MC; Lignon MF; Mendre C; Laur J; Aumelas A; Martinez J
J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological activity of cholecystokinin analogues modified in the Met28-Gly29 region.
Mendre C; Rodriguez M; Lignon MF; Galas MC; Gueudet C; Worms P; Martinez J
Eur J Pharmacol; 1990 Sep; 186(2-3):213-22. PubMed ID: 1705230
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of CCK26-33-related analogues modified in position 31.
Marseigne I; Dor A; Bégué D; Reibaud M; Zundel JL; Blanchard JC; Pélaprat D; Roques BP
J Med Chem; 1988 May; 31(5):966-70. PubMed ID: 2452253
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of N alpha-hydroxysulfonyl-[Nle28,31]-CCK26-33.
Sugg EE; Shook JE; Serra M; Korc M; Yamamura HI; Burks TF; Hruby VJ
Life Sci; 1986 Nov; 39(18):1623-9. PubMed ID: 2430160
[TBL] [Abstract][Full Text] [Related]
18. Action of cholecystokinin analogues on exocrine and endocrine rat pancreas.
Otsuki M; Okabayashi Y; Ohki A; Oka T; Fujii M; Nakamura T; Sugiura N; Yanaihara N; Baba S
Am J Physiol; 1986 Apr; 250(4 Pt 1):G405-11. PubMed ID: 2421584
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of cyclic analogues of cholecystokinin highly selective for central receptors.
Rodriguez M; Amblard M; Galas MC; Lignon MF; Aumelas A; Martinez J
Int J Pept Protein Res; 1990 May; 35(5):441-51. PubMed ID: 2376470
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residue.
Sugg EE; Serra M; Shook JE; Yamamura HI; Burks TF; Korc M; Hruby VJ
Int J Pept Protein Res; 1988 Jun; 31(6):514-9. PubMed ID: 2457563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]